Loading clinical trials...
Loading clinical trials...
Non-interventional Observational Study of Beriplex® P/N in Prophylaxis and Treatment of Acute Bleeding Perioperatively (Diagnostic Intervention or Surgery)
Beriplex® P/N is made from human plasma (the liquid part of the blood) and contains the coagulation factors II, VII, IX and X which are important for blood clotting (coagulation). Lack of any of these factors means that blood does not clot as quickly as it should and so there is an increased tendency to bleed. This observational study was designed to evaluate the effectiveness of Beriplex® P/N in the prevention (prophylaxis) and treatment of bleeding during surgery (perioperative bleeding) in a routine clinical setting.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
Royal Blackburn Hospital
Blackburn, United Kingdom
Blackpool
Blackpool, United Kingdom
Addenbrokes
Cambridge, United Kingdom
Royal Free Hospital
London, United Kingdom
Derriford Hospital
Plymouth, United Kingdom
Southhampton General Hospital
Southhampton, United Kingdom
Start Date
May 1, 2010
Primary Completion Date
January 1, 2012
Completion Date
January 1, 2012
Last Updated
October 3, 2017
445
ACTUAL participants
Beriplex® P/N
BIOLOGICAL
Fresh Frozen Plasma (FFP) and Beriplex® P/N
BIOLOGICAL
Fresh Frozen Plasma
OTHER
Lead Sponsor
CSL Behring
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions